Haemonetics Welcomes New FDA Guidance on Viscoelastic Testing During COVID-19 Pandemic
Go back to Haemonetics Welcomes New FDA Guidance on Viscoelastic Testing During COVID-19 Pandemic| HAEMONETICS CORPORATION (NYSE: HAE) | Delayed: 109.54 +1.13 (1.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $108.41 | 52 Week High | $39.41 | |||
| Open | $106.84 | 52 Week Low | $25.98 | |||
| Day High | $109.56 | P/E | 154.28 | |||
| Day Low | $106.49 | EPS | $0.71 | |||
| Volume | 185,944 | |||||
